|Minimum Order Quantity
|Store below 30 DegreeC
|1 Injection in 1 vial
|Bsn pvt ltd
|1 Injection in 1 vial
Paraplatin Injection, containing the active ingredient Carboplatin, is a chemotherapy medication used in the treatment of various types of cancer, including ovarian cancer, lung cancer, and certain types of brain tumors. Carboplatin belongs to a class of drugs known as platinum-based alkylating agents, which work by interfering with the DNA replication process in rapidly dividing cancer cells, ultimately leading to cell death. Understanding its uses, dosage guidelines, and considerations is essential for healthcare providers and patients undergoing cancer treatment.
Ovarian Cancer: Paraplatin Injection is commonly used as a first-line or adjuvant treatment for ovarian cancer, either alone or in combination with other chemotherapy drugs or surgical interventions. It is effective in both newly diagnosed cases and recurrent or metastatic ovarian cancer, helping to shrink tumors and slow disease progression.
Lung Cancer: Carboplatin is also utilized in the treatment of non-small cell lung cancer (NSCLC), particularly in combination with other chemotherapy agents such as paclitaxel or gemcitabine. It may be administered as part of first-line therapy for advanced or metastatic lung cancer to improve tumor response rates and overall survival.
Other Cancers: In addition to ovarian and lung cancer, Paraplatin Injection may be used in the treatment of other malignancies, including testicular cancer, bladder cancer, and certain types of brain tumors. Its broad spectrum of activity against various cancer types makes it a versatile and valuable chemotherapy agent in oncology practice.
Dosage:The dosage of Paraplatin Injection (Carboplatin) is determined based on several factors, including the patient's body surface area, renal function, performance status, and the specific type and stage of cancer being treated. It is administered intravenously under the supervision of a healthcare professional experienced in chemotherapy administration.
For ovarian cancer, the typical dosage of Carboplatin is calculated based on the Calvert formula, which takes into account the target area under the concentration-time curve (AUC) desired for the individual patient. Common regimens may involve Carboplatin administered at an AUC of 5 to 7.5 every three to four weeks, either as a single agent or in combination with other chemotherapy drugs such as paclitaxel.
For lung cancer and other solid tumors, Carboplatin dosing may vary depending on the specific treatment protocol and combination regimen used. It is often administered in combination with other chemotherapy agents at doses determined by the treating oncologist based on clinical guidelines and individual patient factors.
Side Effects: Common side effects associated with Paraplatin Injection (Carboplatin) may include nausea, vomiting, fatigue, myelosuppression (decreased blood cell counts), neuropathy, and kidney dysfunction. Patients should be monitored closely for signs of toxicity during and after treatment, and supportive care measures may be provided to manage side effects as needed.
Renal Function: Carboplatin is primarily eliminated from the body via the kidneys, and dosage adjustments may be necessary in patients with impaired renal function to minimize the risk of drug accumulation and toxicity. Renal function should be assessed regularly, and dosage adjustments should be made accordingly to ensure safe and effective treatment.
Hematologic Toxicity: Carboplatin can cause myelosuppression, including neutropenia, thrombocytopenia, and anemia, which may increase the risk of infection, bleeding, and fatigue. Regular monitoring of blood cell counts is essential, and dose modifications may be required based on the degree of hematologic toxicity observed.
- Delivery Time: 10 day
- Packaging Details: we ship the parcel directly